Osteoporosis Treatment in Albuquerque

Osteoporosis is a chronic condition requiring long-term management rather than a short-term treatment course. While you'll begin treatment right away, significant bone density improvements typically take 1-2 years to appear on DEXA scans. Most people continue osteoporosis medications for at least 3-5 years, with some requiring longer treatment. Calcium, vitamin D, and exercise recommendations are generally lifelong. The good news is that with consistent treatment, bone density usually stabilizes or improves and fracture risk drops significantly. Dr. Hemmen supports you through this long-term journey with regular monitoring and adjustments as needed.

Not always. Treatment decisions depend on your bone density T-score, fracture risk assessment, age, and other factors. People with osteopenia (low bone density but not quite osteoporosis) and low fracture risk may manage their condition with calcium, vitamin D, weight-bearing exercise, and lifestyle changes alone. However, people with established osteoporosis (T-score of -2.5 or lower), those who've already had fragility fractures, or those at high fracture risk based on FRAX assessment typically benefit significantly from prescription osteoporosis medications. These medications have been proven to reduce fracture risk by 30-50% and are often essential for preventing devastating hip or spine fractures. Dr. Hemmen will discuss the risks and benefits of medication in your specific situation so you can make a shared decision together.

Body1MD is a Direct Primary Care practice and does not bill insurance. Members pay the practice directly: $100 per month under age 50 and $150 per month at age 50 and over, month-to-month with no annual contract. DEXA scans are performed at an outside imaging center and prescriptions are filled at your pharmacy, and Dr. Hemmen's office can explain how outside labs, imaging and prescriptions are handled before you join. In general, Medicare and most insurance plans typically cover DEXA screening for women over 65 and for younger people with risk factors, and generic bisphosphonates like alendronate are usually inexpensive, while newer or brand-name medications may require prior authorization. Many Direct Primary Care members keep insurance or a high-deductible plan for hospital care, specialists and imaging, which can help with the testing and medications that osteoporosis care involves.

First, it's important to understand that stabilizing bone density (preventing further loss) is actually a successful treatment outcome, even if density doesn't increase. That said, if bone density continues to decline despite treatment, Dr. Hemmen will look for potential causes such as missed doses or incorrect administration, malabsorption issues, inadequate calcium or vitamin D levels, undiagnosed secondary causes like hyperparathyroidism, or an inadequate response to the medication. Options include switching to a different class of osteoporosis medication, considering anabolic agents that actively build bone rather than just preventing loss, increasing supplementation, or referral to an endocrinologist for complex cases. The key is regular monitoring with follow-up DEXA scans so a lack of response is detected early and the plan can be adjusted.

Yes. Body1MD members have direct access to Dr. Hemmen by phone and text between visits, which works well for the questions that come up in long-term osteoporosis care, such as a new medication's side effects, lab results, or how to fit in weight-bearing exercise. He will tell you whether a phone check-in is enough or you should come in. Your initial evaluation and periodic physical exams happen in person, and DEXA scans are done at a local imaging center, usually about every 2 years. When you do need to be seen, same- or next-day appointments are available in most cases.

Side effects vary by medication class. Oral bisphosphonates (alendronate, risedronate) can cause esophageal irritation or upset stomach, which is minimized by taking them correctly: on an empty stomach with a full glass of water, remaining upright for 30 minutes afterward. Intravenous bisphosphonates may cause flu-like symptoms for 1-2 days after the infusion, typically only with the first dose. Denosumab injections are generally well-tolerated but require careful attention to dental health. Rare but serious side effects of bisphosphonates include atypical femur fractures and osteonecrosis of the jaw, which are uncommon and more often seen with long-term use. Dr. Hemmen will discuss the specific risks and benefits of any recommended medication, monitor for side effects, and adjust treatment if problems arise. For most people at high fracture risk, the fracture-prevention benefits far outweigh the risks.